海外の腫瘍マーカー検査専門医 — ページ6

Dr. Kim Taegyun is a gastroenterologist. He focuses on pancreatobiliary diseases and cancers, including pancreatitis, pancreatic cysts and cancer, cholecystitis, gallstones (cholelithiasis), and biliary tract cancer. He also performs advanced endoscopy, including ERCP. He treats gastrointestinal tumors, stomach and colon polyps, stomach cancer, and submucosal tumors (SMT).

Education and training: MD, Jeonbuk National University College of Medicine. MS in Medicine, University of Ulsan. Internship, Jeonbuk National University Hospital. Residency in Internal Medicine, Veterans Health Service Medical Center. Fellowships in Gastroenterology, Inje University Haeundae Paik Hospital and Asan Medical Center.

Career: Attending physician and specialist at Gwangju Veterans Hospital and the Veterans Health Service Medical Center.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Dr. Song Hwayeong is a gastroenterologist. Areas of focus include gastrointestinal cancers (stomach and esophageal) and advanced endoscopy (gastroscopy, colonoscopy, ESD, and polypectomy). Dr. Song also treats digestive and liver diseases, including GERD, gastritis, hepatitis, H. pylori infection, and liver disease.

Dr. Song completed a fellowship in Gastroenterology at Inje University Ilsan Paik Hospital. Dr. Song has served as Clinical Professor at Inje, Gachon, and Inha University Colleges of Medicine. Dr. Song is Director of the Gastroenterology Center at Naeun Hospital.

Accreditations: full member of the Korean Association of Internal Medicine, the Korean Society of Gastrointestinal Endoscopy, and the Korean Gastroenterology Association. Doping Committee Member, WKBL.

Selected papers: cryptogenic hepatocellular carcinoma; primary biliary cirrhosis with overlap syndromes; therapy for lamivudine-resistant chronic hepatitis B; and clevudine in HBV-related cirrhosis.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Joseba Rebollo Liceaga is a clinical oncologist at Quirónsalud Alicante. He focuses on personalized cancer treatments and gene-based therapies for metastatic breast cancer. Dr. Rebollo Liceaga teaches as a professor of Multidisciplinary and Personalized Oncology. He treats various conditions, including prostate, colon, and thyroid cancers.

• Former Head of Oncology at Clínica San Miguel and Hospital General de Villalba.
• Researches electrochemotherapy and multidisciplinary approaches for complex cases.
• Practices at JCI-accredited Quirónsalud Torrevieja, a leading center in southeastern Spain.
• Expert in diagnostics using PET-CT, mammography, and tumor marker blood tests.

Dr. Yu Yeonghun is a gastrointestinal surgeon with a Ph.D. in Medicine. He specializes in hepato-pancreato-biliary (HPB) diseases and cancers. His focus includes liver, pancreas, biliary tract, and gallbladder cancers, as well as cholelithiasis and other gallbladder diseases.

He completed his internship and general surgery residency at CHA Bundang Medical Center. He then finished an HPB surgery fellowship at Samsung Medical Center. He has served as Clinical Assistant Professor of Surgery at Konkuk University Choongju Hospital and at Samsung Medical Center. He later became Professor of Surgery at Eulji University Hospital.

He is a Lifetime Member of The Korean Surgical Society and the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS). He serves on the KAHBPS Planning Committee and Tumor Registry Committee.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Oncosurgeon, Head of Samsung Department of Urology

Gynecologist. Oncogynecologist

セバスチャン・ショップマン博士は、一般および内臓外科の優れた専門家です。セバスチャン・ショップマン博士は、ウィーン医科大学の手術大学クリニックの一般外科部門の外科医であり、胃と食道の手術の作業チームを率いています。彼はまた、ウィーンの総合がんセンター（CCC）の胃食道腫瘍ユニット（CCC-GET）の責任者でもあります。ショップマン博士は、240以上の専門記事の著者です。

 職歴: 

• 2014年からオーストリア外科腫瘍学会の総書記 

• 2013年からウィーン総合がんセンター（CCC-GET）、ウィーン医科大学の胃食道がんユニットのコーディネーター 

• 10/2014 ASOコンレス2014の会長

• 2012年4月よりウィーン医科大学手術部門の上部消化管サービスの責任者 

• 2012年からウィーン医科大学の手術機能検査部門の責任者, 手術部門 

• 2010年2月以来、ウィーン医科大学の外科研究ラボの上部消化管研究グループの主任研究者 

• 2009 – 2011 ウィーンオフィスの欧州健康品質学会（ESQH）のディレクター 

• 10/2008 – 2/2009 プリンスコートメディカルセンター（クアラルンプール）のコンサルタント、ウィーン国際医科大学 

• 2007年から上部消化管手術の専門家 

• 2006年以降、ウィーン医科大学の手術部門の准教授 

• ウィーン医科大学 

• 2001 – 2007 ウィーン医科大学手術部門のフェロー 

• 2000 – 2001 IMP – ウィーン分子病理研究所にて学外で博士号取得 

• 1999 – 2000 ウィーン医科大学の病理学臨床研究所のフェロー 

コンサルティングエディターとして: • Annals of Surgical Oncology, Journal of Leucocyte Biology, Acta Biologica Hungarica, British Journal of Cancer, British Journal of Surgery, Oncology, Deutsche Forschungsgemeinschaft (DFG), British Journal of Oncology, BMC Cancer, Cell and Molecular Life Science, World Journal of Surgical Oncology, Breast Care, European Journal of surgical Oncology, Journal for Cellular and Molecular Biology, • Journal of Leucocyte Biologyコンサルティングエディター、European Journal of Surgical Oncologyの副編集長、European Surgeryのセクションエディター

Chief Physician of the Oncology Center, Oncologist

Gynecologist, Specialist in endoscopic and laparoscopic operations

Oncohematologist

Dr. Cemalettin Aydin is a professor of general surgery at Medipol Acibadem District Hospital in Istanbul. He specializes in gastroenterology surgery and complex weight loss procedures. He completed a prestigious fellowship in gastroenterology surgery at the Türkiye High Specialization Hospital.

• Performs advanced bariatric surgeries including gastric bypass and sleeve gastrectomy.
• Treats complex gastrointestinal conditions such as pancreatitis, Crohn's disease, and cirrhosis.
• Expert in endoscopic sleeve gastroplasty (ESG) and laparoscopic anti-reflux surgery.
• Works at Medipol Acibadem, a JCI-accredited facility using the da Vinci robotic system.